Ionis Pharmaceuticals Inc (IONS)
38.76
+0.37
(+0.96%)
USD |
NASDAQ |
Nov 01, 16:00
38.76
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Total Assets (Quarterly): 2.691B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.691B |
| March 31, 2024 | 2.764B |
| December 31, 2023 | 2.990B |
| September 30, 2023 | 2.934B |
| June 30, 2023 | 2.971B |
| March 31, 2023 | 2.885B |
| December 31, 2022 | 2.534B |
| September 30, 2022 | 2.422B |
| June 30, 2022 | 2.456B |
| March 31, 2022 | 2.519B |
| December 31, 2021 | 2.612B |
| September 30, 2021 | 2.415B |
| June 30, 2021 | 2.497B |
| March 31, 2021 | 2.249B |
| December 31, 2020 | 2.390B |
| September 30, 2020 | 3.096B |
| June 30, 2020 | 3.079B |
| March 31, 2020 | 3.091B |
| December 31, 2019 | 3.233B |
| September 30, 2019 | 2.895B |
| June 30, 2019 | 2.878B |
| March 31, 2019 | 2.836B |
| December 31, 2018 | 2.668B |
| September 30, 2018 | 2.248B |
| June 30, 2018 | 2.247B |
| Date | Value |
|---|---|
| March 31, 2018 | 1.300B |
| December 31, 2017 | 1.323B |
| September 30, 2017 | 1.253B |
| June 30, 2017 | 1.091B |
| March 31, 2017 | 1.084B |
| December 31, 2016 | 912.47M |
| September 30, 2016 | 843.59M |
| June 30, 2016 | 811.11M |
| March 31, 2016 | 875.82M |
| December 31, 2015 | 947.90M |
| September 30, 2015 | 988.00M |
| June 30, 2015 | 976.26M |
| March 31, 2015 | 955.43M |
| December 31, 2014 | 955.81M |
| September 30, 2014 | 793.80M |
| June 30, 2014 | 817.78M |
| March 31, 2014 | 834.62M |
| December 31, 2013 | 847.16M |
| September 30, 2013 | 881.92M |
| June 30, 2013 | 788.65M |
| March 31, 2013 | 552.96M |
| December 31, 2012 | 545.69M |
| September 30, 2012 | 485.68M |
| June 30, 2012 | 472.39M |
| March 31, 2012 | 470.81M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.249B
Minimum
Mar 2021
3.233B
Maximum
Dec 2019
2.728B
Average
2.691B
Median
Jun 2024
Total Assets (Quarterly) Benchmarks
| Biogen Inc | 28.31B |
| Alnylam Pharmaceuticals Inc | 4.205B |
| Biomarin Pharmaceutical Inc | 6.851B |
| Rigel Pharmaceuticals Inc | 128.41M |
| Apellis Pharmaceuticals Inc | 904.48M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.427B |
| Shareholders Equity (Quarterly) | 263.70M |
| Debt to Equity Ratio | 4.842 |
| Current Ratio | 7.608 |
| Net Debt Paydown Yield | -0.27% |